Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1991 2
1993 2
1998 1
2002 3
2004 1
2006 1
2013 1
2015 2
2017 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
[Evidence-based recommendations on primary treatment of carcinomas of the breast].
Von Minckwitz G, Brunnert K, Costa SD, Friedrichs K, Jackisch Ch, Gerber B, Harbeck N, Junkermann H, Möbus V, Nitz U, Schaller G, Scharl A, Thomssen Ch, Untch M; Conssensus of the AGO Organ Commission "Mamma". Von Minckwitz G, et al. Among authors: brunnert k. Zentralbl Gynakol. 2002 May;124(5):293-303. doi: 10.1055/s-2002-34095. Zentralbl Gynakol. 2002. PMID: 12232814 Review. German. No abstract available.
[Evidence-based recommendations on treating locoregional and distant metastases of carcinomas of the breast].
Von Minckwitz G, Costa SD, Brunnert K, Dall P, Nitz U, Diel I, Fersis N, Friedrich M, Friedrichs K, Thomssen Ch, Gerber B, Göhring UJ, Harbeck N, Hanf V, Schaller G, Scharl A, Schmutzler R, Simon WE, Untch M; Consensus of the AGO Organ Commission "Mamma". Von Minckwitz G, et al. Among authors: brunnert k. Zentralbl Gynakol. 2002 May;124(5):284-92. doi: 10.1055/s-2002-34094. Zentralbl Gynakol. 2002. PMID: 12232813 Review. German. No abstract available.
Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer--a multicentre, open, controlled, prospectively randomised trial.
von Minckwitz G, Loibl S, Brunnert K, Kreienberg R, Melchert F, Mösch R, Neises M, Schermann J, Seufert R, Stiglmayer R, Stosiek U, Kaufmann M. von Minckwitz G, et al. Among authors: brunnert k. Eur J Cancer. 2002 Nov;38(17):2265-71. doi: 10.1016/s0959-8049(02)00378-7. Eur J Cancer. 2002. PMID: 12441263 Clinical Trial.
[Pregnancy luteoma, a differential diagnostic problem].
Feldmann A, Placke J, Brunnert K, Schulz H. Feldmann A, et al. Among authors: brunnert k. Geburtshilfe Frauenheilkd. 1991 Feb;51(2):146-7. doi: 10.1055/s-2007-1023692. Geburtshilfe Frauenheilkd. 1991. PMID: 1645693 German.
Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer.
Kaufmann M, Jonat W, Abel U, Hilfrich J, Caffier H, Kreienberg R, Trams G, Brunnert K, Schermann J, Kleine W, et al. Kaufmann M, et al. Among authors: brunnert k. J Clin Oncol. 1993 Mar;11(3):454-60. doi: 10.1200/JCO.1993.11.3.454. J Clin Oncol. 1993. PMID: 8445420 Clinical Trial.
16 results